1/199
Looks like no tags are added yet.
Pharmacology
the scientific study of the actions of drugs and their effects on a living organism
Neuropharmacology
concerned w/drug-induced changes to nervous system
Psychopharmacology
concerned w/drug-induced changes in mood, thinking, and behaviour
Neuropsychopharmacology
identify chemicals that can alter behaviour with a focus on the underlying neurobiology
Drug action
specific molecular changes produced when drug binds to a particular target site or receptor
Drug effects
alterations in physiological or psychological functions
Therapeutic effect
drug produces desired physical or behavioural changes
Side effects
non-therapeutic effects
Specific drug effects
based on physical and biochemical interactions of a drug with a target site in living tissue
Nonspecific drug effects
based on unique characteristics of the individual
Placebo
pharmacologically inert compound; may have therapeutic effects and side effects; effects include measurable physiological changes; may be due to pavlovian conditioning, verbal suggestion, positive expectations, social learning, or genetics
Nocebo effect
increased anxiety or pain due to negative expectations
Double-blind experiment
neither patient nor observer knows what treatment the participant has received
Pharmacokinetics
how the body absorbs, distributes, metabolizes, and excretes drugs
Bioavailability
amount of drug in the blood that is free to bind at specific target sites
Systemic routes of drug administration
drug moves throughout the body through general circulation
Oral administration (PO)
drug must pass through stomach or intestine wall to reach blood capillaries; must be resistant to destruction by stomach acid and enzymes
Absorption
movement of drug from the site of administration to the blood circulation
First-pass metabolism
ingested chemicals pass via the portal vein to the liver, where they are altered by enzymes before passing to the general circulation; oral therapeutic drugs may undergo metabolism that reduces their bioavailability
Intravenous (IV)
rapid and accurate; drug goes directly into bloodstream; danger of overdose
Intramuscular (IM) injection
slower, more even absorption over time
Subcutaneous (SC) injection
just below the skin; drug pellets can be used to deliver hormones such as contraceptives
Inhalation
drug is absorbed by passing through the lungs
Topical application to mucus membranes
results in local effects
Intranasal
local effects but moves rapidly into blood; avoids first-pass metabolism; bypasses blood-brain barrier
Transdermal
through the skin with skin patches; avoids first-pass metabolism
Epidural
injection into epidural space; bypasses blood-brain barrier
Rectal administration
rectum is highly vascularized and can directly absorb alcohol; partially reduces first pass metabolism; alcohol may move into colon, where there is no alcohol dehydrogenase; BAC elevated much more than equivalent quantity PO; cannot regurgitate from the butt
Other factors affecting pharmacokinetics
route of administration, drug concentration, solubility and ionization of the drug, rate of transport across cell membranes - bilayers of phospholipid molecules
Lipid-soluble drugs
move through cell membranes by passive diffusion: diffusion is from higher to lower concentration (concentration gradient)
Bioactivation
inactive drug is metabolized into an active form (ex. Heroin → morphine)
Degree of ionization
depends on pH and pKa
pKa
pH of the solution in which that drug would be 50% ionized and 50% non-ionized; non-ionized form is more lipid soluble, can pass cell membranes and enter the blood more easily
Drug redistribution
can terminate drug action
Blood-brain barrier
separation between brain capillaries and cerebrospinal fluid (CSF); selectively permeable
Brain capillaries
endothelial cells are fused by tight junctions; most materials move by special transporters; these are surrounded by extensions of astroglia (astrocytes); essential to maintaining the blood-brain barrier
Depot binding
alters the magnitude and duration of drug action; binding of drugs to inactive sites (drug depots or “silent receptors”; ex. Albumen and fat) affects magnitude and duration of drug action; reduces concentration of drug at action sites; nonselective binding can cause competition between drugs and possible overdose; bound drug molecules can be altered by liver enzymes - prolongs time drug is in the body; redist to inactive sites; ex. THC and fentanyl
Biotransformation (metabolism) and excretion
eliminate drugs from the body
First order kinetics
drug clearance from the blood is exponential; alcohol metabolism follows zero-order kinetics
Half-life
amount of time required for removal of 50% of the drug (t1/2)
Most biotransformation occurs in the liver
phase 1: oxidation, reduction, or hydrolysis; phase 2: synthetic reactions: products are ionized, water soluble, and biologically inactive; drugs that are converted to active metabolites have a prolonged duration of action (ex. Lisdexamphetamine [vyvanse])
Enzyme induction
repeated use of drug increases number of enzymes; increases rate of metabolism
Enzyme inhibition
reduces metabolism of other drugs that use the same enzyme
Drug competition
elevated levels of one drug reduces metabolism of the second
Individual differences in age, gender, and genetics can also affect drug metabolism
CYP450 polymorphism
Drug elimination
urine is most important route for drug elimination; kidneys filter materials from the blood, unless large or bound to plasma proteins; ionization reduces reabsorption; urinary pH affects drug reabsorption in kidney tubules; altering the pH is used to treat drug toxicity
Pharmacodynamics
study of the interaction of drug molecules with specific receptors
Receptors
proteins on cell surfaces or within cells; cell surface receptors relay information through the cell membrane, intracellular receptors within cytoplasm or nucleus of target cells
Ligand
molecule that binds to a receptor with some selectivity
Receptor agonists
have high affinity for a receptor; bind to receptor and initiate a cellular response
Receptor antagonists
bind to receptor but produce no effects (low efficacy); also prevent agonists from binding
Partial agonists
have intermediate efficacy
Inverse agonists
initiate an action opposite to that produced by an agonist
Dose-response curve
describes extent of biological or behavioural effect produced by a given drug concentration (dose)
50% effective dose (ED50)
the dose that produces half the maximal effect
Threshold
dose that produces the smallest measurable response
Potency
amount of drug necessary to produce a specific effect; comparing ED50 of different drugs shows differences in potency, even if they have identical efficacy
TD50 (50% toxic dose)
dose at which 50% of the population experiences a toxic effect; comparing TD50 with ED50 helps to determine appropriate doses to prevent toxic effects
Therapeutic index (TI)
TD50 / ED50
Competitive antagonists
compete with agonists to bind receptors but don’t initiate effects, reducing effect of the agonist; can be displaced by an excess of agonist
Noncompetitive antagonists
reduce effect of agonists in other ways
Tolerance
a diminished response resulting in need for larger doses to be administered to obtain same magnitude of response
Cross-tolerance
tolerance to one drug can diminish effectiveness of a second drug
Acute tolerance
develops after one administration
Metabolic tolerance
when drugs increase their own rate of metabolism by liver microsomal enzyme induction
Pharmacodynamic tolerance
neural function changes to adapt to continued presence of the drug by up- or down-regulation
Behavioural tolerance
occurs in the same environment in which the drug was administered
Pavlovian or classical conditioning
the drug taking procedure or the environment may elicit a conditioned response
Operant conditioning
ex. An individual with alcohol use disorder learns to maneuver efficiently while intoxicated
State-dependent learning
tasks learned under the influence of a psychoactive drug may then be performed better in the drugged state
Sensitization or reverse tolerance
enhancement of drug effects after repeated administration; cross-sensitization has also been documented
Embryonic stem cells
Differentiate into specialized specialized neural cells
Neurons
transmit information in the form of electrical signaling
Glial cells
provide metabolic support, protection, and insulation
Sensory neurons
convert physical stimuli into electrical signals
Motor neurons
direct biobehavioural responses appropriate for the situation
Interneurons
in brain and spinal cord; form interacting neural circuits
Soma
cell body, performs most metabolic functions
Dendrites
receive information from other cells across the synapse between them
Axon
conducts signal (generated at axon hillock) from cell body to axon terminal
Nerve cells (neurons)
like other cells, have a cell membrane, cytoplasm, nucleus, mitochondria, and are bathed in extracellular fluid
Dendrites and soma
have thousands of receptors that respond to chemical signals, effect may be excitatory or inhibitory
Convergence
each neuron receives/integrates information from many cells
Divergence
information may be transmitted to a few or thousands of other neurons
Dendritic spines
increase the receiving surface area
Axon collaterals
formed through branching of axons
Synaptic vesicles
contain neurotransmitter chemicals
Myelin sheath
a fatty insulating coating created by layers of glial cells
Nodes of ranvier
breaks in the myelin sheath, where action potentials are regenerated
Chromosomes
strands of DNA
Gene
section of chromosome that codes for a specific protein
Transcription factors
proteins that promote or obstruct formation of mRNAs by binding to the promoter region of the gene, modifying its rate of transcription
Transcription
production of complementary mRNA from DNA; takes place in nucleus
Translation
building protein molecules by linking amino acids (making proteins) specified by mRNA; takes place on ribosomes in the cytoplasm
Epigenetics
control of gene expression by chromosome modifications that don’t affect the DNA code
DNA methylation: attachment of methyl groups
Chromatin remodeling: chemical modification of histone tails promotes or prevents transcription and changes gene expression
Epigenetic modification can occur in response to environmental factors or drugs
Epigenetic changes may help explain addictions and aspects of neurological and psychiatric disorders
Axoplasmic transport
proteins made in the soma must be transported to the axon terminals
Cytoskeleton
microtubules and neurofilaments that provide the cell shape
Microtubules form a track for protein transport to the axon terminals and back
Proteins in the cell membrane
include receptors, enzymes, ion channels, and transporters
Most ion channels are gated channels
Ligand-gated channel: opens when a ligand binds to a receptor
Voltage-gated channel: opens when electrical potential across the membrane is altered
Some ion channels are modified by second messengers
Resting membrane potential
inside of cell is more negative than outside; at -70mV it is polarized